Isabella Garagiola

Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura

Luca A. Lotta, Haifeng Wu, Ian Mackie et al. · Blood · 2012 · 120 citations · Full text

Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A

Maria Elisa Mancuso, Pier Mannuccio Mannucci, Angiola Rocino et al. · Journal of Thrombosis and Haemostasis · 2012 · 56 citations · Full text

Inhibitor Development, Hematology, Pathology +7

Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients

Marcin M. Gorski, Kevin Blighe, Luca A. Lotta et al. · Blood · 2016 · 36 citations

Mutations in theMCFD2 gene and a novel mutation in theLMAN1 gene in Indian families with combined deficiency of factor V and VIII

Dipika Mohanty, Kanjaksha Ghosh, Shrimati Shetty et al. · American Journal of Hematology · 2005 · 26 citations

Source of Factor VIII Replacement (PLASMATIC OR RECOMBINANT) and Incidence of Inhibitory Alloantibodies in Previously Untreated Patients with Severe Hemophilia a: The Multicenter Randomized Sippet Study

Flora Peyvandi, Pier Mannuccio Mannucci, Isabella Garagiola et al. · Blood · 2015 · 21 citations